Hemovent
Hemovent GmbH, headquartered in Aachen, Germany, develops and manufactures the MOBYBOX and MOBYO—compact, fully pneumatic ECLS and oxygenator systems—selling them CE-marked as capital equipment to hospitals for emergency, intensive care, transport, and cath-lab use.
- Company typePrivate
- Founded2013
- HeadquartersAachen, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Hemovent does
Hemovent GmbH, founded in 2013 and headquartered in Aachen, Germany, is a privately held medical device company that develops and manufactures mobile extracorporeal life support (ECLS) systems. Its core products are the MOBYBOX™, the first fully pneumatically driven ECLS system that integrates a biventricular displacement pump and gas exchanger in a single ~2 kg unit operating without external electricity or software, and the MOBYO™, a standalone round-design gas exchanger (oxygenator) with flow-optimized geometry that can be paired with the MOBYBOX or with most conventional rotational pumps. The 12+ worldwide patents, ISO 13485:2016 quality management certification, and CE marking under EU MDR 2017/745 (14-day intended use for MOBYBOX, 28-day for MOBYO) form the technical and regulatory backbone of the business.
The company's go-to-market is sales-led B2B, targeting hospitals and healthcare institutions through direct consultation requests addressed to intensive care, emergency medicine, anesthesiology, and cardiac catheterization departments. Use cases span emergency resuscitation, ARDS, cardiogenic failure, septic shock, high-risk PCI in cath labs, and intra/inter-hospital transport of ECLS patients. The hardware-centric product positioning—differentiating on rapid ~5-minute setup, mobility, shock-resistance, and reduced blood trauma via pulsatile flow—is the primary commercial narrative, supported by participation in international medical conferences and peer-reviewed publications in Ann Thorac Surg and ASAIO Journal. Revenue is generated through capital-equipment sales with quote-based pricing to enterprise healthcare buyers; specific contract values and unit volumes are not disclosed.
Since the late 2010s, Hemovent has operated under the umbrella of Microport MedTech, a global medical technology corporation, retaining its Aachen headquarters and cleanroom manufacturing facility and 100% in-house development. The disclosed funding history includes a $6.0M round in February 2016 led by MIG Capital, a ~$2.33M round in July 2017, and a $5.2M round in February 2019; no further capital raises are evidenced in the input. Day-to-day leadership is held by Managing Director Frank Schanne, alongside co-founder Christof Lenz (CEO) and CTO Oliver Marseille.
Hemovent firmographics
Firmographics- Name
- Hemovent
- Legal name
- Hemovent GmbH
- Website
- https://hemovent.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Hemovent GmbH, headquartered in Aachen, Germany, develops and manufactures the MOBYBOX and MOBYO—compact, fully pneumatic ECLS and oxygenator systems—selling them CE-marked as capital equipment to hospitals for emergency, intensive care, transport, and cath-lab use.
- Ownership category
- akta.pro rank
Hemovent industry classification
Industry- Product category
- Extracorporeal Life Support (ECLS) Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro industry
- Mechanical Circulatory Support (VAD, IABP, ECMO)Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Keywords
Where Hemovent is headquartered
LocationHeadquarters
- HQ city
- Aachen
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Hemovent business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Hemovent generates revenue through the sale of its medical devices including the MOBYBOX ECLS system and MOBYO oxygenator. As a medical device manufacturer, the company sells hardware products to hospitals and healthcare institutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for hospitals and healthcare institutions |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Hemovent product offering
Product offeringCore offering
Hemovent designs, manufactures, and sells the MOBYBOX™, a compact (~2 kg) fully pneumatically driven extracorporeal life support (ECLS) system that integrates a biventricular displacement pump and gas exchanger in a single unit requiring no external electrical power or software. The company also sells the MOBYO™, a stand-alone round-design oxygenator compatible with both the MOBYBOX and conventional rotational pumps, targeting emergency resuscitation, cardiac and pulmonary support, transport, and patient mobilization in hospitals and ICUs.
Product overview
Hemovent offers two modular ECLS (extracorporeal life support) products: the MOBYBOX™ as the core integrated system and the MOBYO™ as a standalone oxygenator module. The MOBYBOX™ is a fully pneumatically driven, compact ECLS unit combining a displacement pump and gas exchanger in one ~2 kg device, requiring no external power or software, and supporting both veno-venous and veno-arterial configurations for emergency, stabilization, transport, and patient mobilization. The MOBYO™ serves as a flow-optimized, round-design gas exchanger that functions as an integral component of the MOBYBOX™ system and can also be paired independently with conventional rotational pumps. Both products are manufactured in-house in Aachen, Germany, and carry CE marking under MDR 2017/745.
Differentiator
Problem solved
Functional benefit
Brands
- MOBYBOX™: A compact, fully pneumatically driven ECLS (Extracorporeal Membrane Oxygenation) system that combines a displacement pump and gas exchanger in one unit. Weighs approximately 2kg and operates without external power or software.
- MOBYO™
Products and services
- MOBYBOX™ The MOBYBOX™ is a fully pneumatically driven, compact (~2 kg) extracorporeal life support (ECLS) system integrating a biventricular displacement pump and gas exchanger into a single unit. It supports veno-venous and veno-arterial heart/lung configurations, requires no external power or software, and is targeted at emergency, stabilization, transport, and patient mobilization use in ICUs, emergency departments, cath labs, and field settings. CE certified under MDR 2017/745 with a 14-day intended use.
- MOBYO™ The MOBYO™ is a standalone round-design gas exchanger (oxygenator) with flow-optimized geometry that minimizes stagnation areas and thrombus formation. It functions as an integral component of the MOBYBOX system and can also be paired independently with most conventional rotational pumps. Supports blood flows up to 7 L/min, ships as a complete set including tubing, clamps, scissors, and a deaeration kit, and is CE certified under MDR with a 28-day intended use.
Quantifiable outcome
- Setup time of approximately 5 minutes
- +4 more outcomes
Companies that use Hemovent
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles2 records
Hemovent technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Hemovent partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MicroportcoreHemovent operates under the umbrella of Microport MedTech, a global medical technology corporation. Today, the headquarters and production facility with clean room in Aachen operate under the Microport group. This provides Hemovent with the resources and global reach of a major MedTech corporation while maintaining its innovation lab and development operations in Aachen.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Hemovent competitors and assessment
Company assessmentBroad incumbents
- Getinge (Maquet Cardiohelp): Global leader in ECLS/ECMO via the Maquet Cardiohelp system, the dominant installed base in ICUs worldwide. Directly comparable as a full ECLS platform competitor, with deep clinical-evidence, KOL relationships, and global service infrastructure.
- Medtronic: Sells the Affinity family of centrifugal blood pumps and oxygenators used in ECLS circuits. Comparable as a broad incumbent with overlapping ECLS hardware, much larger R&D and hospital sales coverage.
- Terumo Corporation: Sells perfusion systems, centrifugal pumps, and oxygenators used in cardiac surgery and ECMO. Comparable as a broad incumbent with overlapping cardiopulmonary hardware and global hospital reach.
- Abiomed (Johnson & Johnson): Acquired Abiomed for its Impella percutaneous ventricular assist devices — adjacent but overlapping in temporary mechanical circulatory support sales motion to the same ICU/cath-lab customers Hemovent targets.
Direct peers
- LivaNova (TandemLife / LifeSPARC): Markets the TandemLife / LifeSPARC ECLS platform for ECMO and temporary mechanical circulatory support. Closely comparable in product category (portable ECMO/ECLS) and target clinical use case.
- Fresenius Medical Care (Xenios): Acquired Xenios to build an ECLS/ECMO franchise around the i-cor and Hilite product lines. Direct competitor in mini-invasive and respiratory/circulatory support, sharing the same European intensivist customer base.
Emerging players
- Spectrum Medical: UK-based specialist in extracorporeal support equipment including Quantum and other perfusion/ECLS technologies. Comparable as a focused ECLS challenger, similar in scale and product niche.
- Eurosets: Italian manufacturer of ECMO and ECLS devices including oxygenators and pumps. Direct product overlap with MOBYBOX/MOBYO; comparable as a smaller European ECLS specialist competing for similar hospital accounts.
- Berlin Heart: Specialist in mechanical circulatory support (ventricular assist devices) used in pediatric and adult cardiac failure. Comparable as a focused cardiovascular-support device specialist in overlapping clinical indications.
Regional players
- Nipro Corporation: Japan-headquartered medtech firm selling ECMO/cardiopulmonary support systems and consumables into Asian and select global markets. Comparable product overlap in oxygenators and ECLS hardware, primarily regional rather than Europe-centric.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Hemovent social profiles
Digital presenceHemovent compliance and trust
Trust signalCompliance2 records
Hemovent financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hemovent leadership team
Management profileNumber of profiles
Profiles3 records
Hemovent funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hemovent M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hemovent
What does Hemovent do?
Hemovent designs, manufactures, and sells the MOBYBOX™, a compact (~2 kg) fully pneumatically driven extracorporeal life support (ECLS) system that integrates a biventricular displacement pump and gas exchanger in a single unit requiring no external electrical power or software. The company also sells the MOBYO™, a stand-alone round-design oxygenator compatible with both the MOBYBOX and conventional rotational pumps, targeting emergency resuscitation, cardiac and pulmonary support, transport, and patient mobilization in hospitals and ICUs.
Is Hemovent a public or private company?
Hemovent is a private company. It is classified as corporate owned and is currently operating.
When was Hemovent founded?
Hemovent was founded in 2013. It employs 11 to 50 people.
Where is Hemovent based?
Hemovent is headquartered in Aachen, Germany, in the Europe region.
How does Hemovent make money?
One revenue line is on record: medical Device Sales.
Who are Hemovent's main competitors?
Broad incumbents on record are Getinge (Maquet Cardiohelp), Medtronic, Terumo Corporation and Abiomed (Johnson & Johnson). Direct peers are LivaNova (TandemLife / LifeSPARC) and Fresenius Medical Care (Xenios). Emerging players are Spectrum Medical, Eurosets and Berlin Heart. Nipro Corporation is listed as a regional player.
Does Hemovent have an API?
No public API is recorded for Hemovent.
What industry is Hemovent in?
Hemovent's product category is Extracorporeal Life Support (ECLS) Medical Devices. Its primary akta.pro industry code is HLAHAFAG, Mechanical Circulatory Support (VAD, IABP, ECMO), with a secondary code of HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home). Its NAICS code is 334510 and its SIC code is 3845.